Karch CP - Search Results

1

The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back.

Karch CP, Burkhard P, Matyas GR, Beck Z. Karch CP, et al. Nanomedicine (Lond). 2021 Apr;16(8):673-680. doi: 10.2217/nnm-2020-0450. Epub 2021 Mar 10. Nanomedicine (Lond). 2021. PMID: 33715403 Free article.

2

Self-assembling protein nanoparticles: a promising tool against lethal influenza?

Burkhard P, Karch CP. Burkhard P, et al. Among authors: karch cp. Nanomedicine (Lond). 2017 Jul;12(13):1529-1531. doi: 10.2217/nnm-2017-0148. Epub 2017 Jun 16. Nanomedicine (Lond). 2017. PMID: 28621581 No abstract available.

3

Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine development.

Karch CP, Matyas GR, Burkhard P, Beck Z. Karch CP, et al. Nanomedicine (Lond). 2018 Sep;13(17):2121-2125. doi: 10.2217/nnm-2018-0222. Epub 2018 Oct 1. Nanomedicine (Lond). 2018. PMID: 30270731 Free article. Review. No abstract available.

4

Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen.

Karch CP, Bai H, Torres OB, Tucker CA, Michael NL, Matyas GR, Rolland M, Burkhard P, Beck Z. Karch CP, et al. Nanomedicine. 2019 Feb;16:206-216. doi: 10.1016/j.nano.2018.12.001. Epub 2018 Dec 18. Nanomedicine. 2019. PMID: 30576800

5

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation.

Karch CP, Burkhard P, Matyas GR, Beck Z. Karch CP, et al. J Vis Exp. 2019 Aug 21;(150). doi: 10.3791/60103. J Vis Exp. 2019. PMID: 31498330

6

Impact of the expression system on the immune responses to self-assembling protein nanoparticles (SAPNs) displaying HIV-1 V1V2 loop.

Karch CP, Paquin-Proulx D, Eller MA, Matyas GR, Burkhard P, Beck Z. Karch CP, et al. Nanomedicine. 2020 Oct;29:102255. doi: 10.1016/j.nano.2020.102255. Epub 2020 Jun 29. Nanomedicine. 2020. PMID: 32615339 Free article.

7

The current and future role of nanovaccines in HIV-1 vaccine development.

Karch CP, Matyas GR. Karch CP, et al. Expert Rev Vaccines. 2021 Aug;20(8):935-944. doi: 10.1080/14760584.2021.1945448. Epub 2021 Jun 29. Expert Rev Vaccines. 2021. PMID: 34184607 Free article. Review.

8

Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity.

Schneider CG, Taylor JA, Sibilo MQ, Miura K, Mallory KL, Mann C, Karch C, Beck Z, Matyas GR, Long CA, Bergmann-Leitner E, Burkhard P, Angov E. Schneider CG, et al. Vaccines (Basel). 2021 Jan 29;9(2):103. doi: 10.3390/vaccines9020103. Vaccines (Basel). 2021. PMID: 33572803 Free PMC article.

9

Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge.

Karch CP, Li J, Kulangara C, Paulillo SM, Raman SK, Emadi S, Tan A, Helal ZH, Fan Q, Khan MI, Burkhard P. Karch CP, et al. Nanomedicine. 2017 Jan;13(1):241-251. doi: 10.1016/j.nano.2016.08.030. Epub 2016 Sep 2. Nanomedicine. 2017. PMID: 27593488

10

The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.

Karch CP, Doll TAPF, Paulillo SM, Nebie I, Lanar DE, Corradin G, Burkhard P. Karch CP, et al. J Nanobiotechnology. 2017 Sep 6;15(1):62. doi: 10.1186/s12951-017-0295-0. J Nanobiotechnology. 2017. PMID: 28877692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters